1,638
Views
21
CrossRef citations to date
0
Altmetric
Drug Profile

Tocilizumab for the treatment of giant cell arteritis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 339-349 | Received 31 Jan 2018, Accepted 19 Apr 2018, Published online: 09 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Reena Shah, Jasmit Shah, Jaimini Gohil, Gunturu Revathi & Salim Surani. (2022) Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya. International Journal of General Medicine 15, pages 2415-2425.
Read now

Articles from other publishers (20)

Mariana Boulos, Tamara Bassal, Asad Layyous, Maamoun Basheer & Nimer Assy. (2022) Inflammation in COVID-19: A Risk for Superinfections. COVID 2:11, pages 1609-1624.
Crossref
Davis C. Thomas, Prisly Thomas, Deep P. Pillai, Dahlia Joseph, Upasana Lingaiah, Blessy C. Mathai, Anjali Ravi, Surabhi Chhabra & Priyanka Kodaganallur Pitchumani. (2022) Giant Cell Arteritis: A Case-Based Narrative Review of the Literature. Current Pain and Headache Reports 26:10, pages 725-740.
Crossref
Martin Wenger & Michael Schirmer. (2022) Indications for diagnostic use of nuclear medicine in rheumatology: A mini-review. Frontiers in Medicine 9.
Crossref
Aileen A Antonio, Ronel N Santos & Samuel A Abariga. (2022) Tocilizumab for giant cell arteritis. Cochrane Database of Systematic Reviews 2022:5.
Crossref
Vera Nezgovorova, Casara Jean Ferretti, Stefano Pallanti & Eric Hollander. (2022) Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. Journal of Psychiatric Research 149, pages 367-373.
Crossref
Giovanni Dolci, Giulia Cassone, Giulia Besutti, Romina Corsini, Fabio Sampaolesi, Valentina Iotti, Elena Galli, Adalgisa Palermo, Matteo Fontana & Pamela Mancuso. (2022) Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study. The Brazilian Journal of Infectious Diseases 26:1, pages 101702.
Crossref
Aileen A Antonio, Ronel N Santos & Samuel A Abariga. (2021) Tocilizumab for giant cell arteritis. Cochrane Database of Systematic Reviews 2021:8.
Crossref
Vijairam Selvaraj, Mohammad Saud Khan, Chirag Bavishi, Kwame Dapaah-Afriyie, Arkadiy Finn, Amos Lal & Eleftherios Mylonakis. (2021) Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials. Lung 199:3, pages 239-248.
Crossref
Michael Schirmer & Rick McCutchan. 2021. Large and Medium Size Vessel and Single Organ Vasculitis. Large and Medium Size Vessel and Single Organ Vasculitis 65 79 .
Carlo Salvarani, Giovanni Dolci, Marco Massari, Domenico Franco Merlo, Silvio Cavuto, Luisa Savoldi, Paolo Bruzzi, Fabrizio Boni, Luca Braglia, Caterina Turrà, Pier Ferruccio Ballerini, Roberto Sciascia, Lorenzo Zammarchi, Ombretta Para, Pier Giorgio Scotton, Walter Omar Inojosa, Viviana Ravagnani, Nicola Duccio Salerno, Pier Paolo Sainaghi, Alessandro Brignone, Mauro Codeluppi, Elisabetta Teopompi, Maurizio Milesi, Perla Bertomoro, Norbiato Claudio, Mario Salio, Marco Falcone, Giovanni Cenderello, Lorenzo Donghi, Valerio Del Bono, Paolo Luigi Colombelli, Andrea Angheben, Angelina Passaro, Giovanni Secondo, Renato Pascale, Ilaria Piazza, Nicola Facciolongo & Massimo Costantini. (2021) Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia. JAMA Internal Medicine 181:1, pages 24.
Crossref
Reza Malekzadeh, Atefeh Abedini, Behzad Mohsenpour, Ehsan Sharifipour, Roya Ghasemian, Seyed Ali Javad-Mousavi, Rozita Khodashahi, Mahboobeh Darban, Saeed Kalantari, Nafiseh Abdollahi, Mohammad Reza Salehi, Abbas Rezaei Hosseinabadi, Farzin Khorvash, Melika Valizadeh, Farzaneh Dastan, Sahar Yousefian, Hamed Hosseini, Nassim Anjidani & Payam Tabarsi. (2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology 89, pages 107102.
Crossref
Maria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Facciolongo, Fiorentino Fraganza, AnnaMaria Marata, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Roberto Parrella, Patrizia Popoli, Gerardo Botti, Laura Arenare, Paolo Chiodini, Ciro Gallo, Carlo Salvarani & Francesco Perrone. (2020) TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemporary Clinical Trials 98, pages 106165.
Crossref
Francesco Muratore, Luigi Boiardi, Giovanna Restuccia, Alberto Cavazza, Mariagrazia Catanoso, Pierluigi Macchioni, Lucia Spaggiari, Luca Cimino, Raffaella Aldigeri, Nicolò Pipitone, Antonio Fontana, Massimiliano Casali, Stefania Croci & Carlo Salvarani. (2020) Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study. Seminars in Arthritis and Rheumatism 50:4, pages 549-558.
Crossref
Giacomo De Luca, Corrado Campochiaro, Silvia Sartorelli, Giovanni Peretto & Lorenzo Dagna. (2020) Therapeutic strategies for virus-negative myocarditis: a comprehensive review. European Journal of Internal Medicine 77, pages 9-17.
Crossref
Mikiko Kobayashi, Yuki Matsumoto, Hidetoshi Satomi, Ayako Tateishi, Maki Ohya, Ichiro Ito & Hiroyuki Kanno. (2020) The ratio of CD163-positive macrophages to Iba1-positive macrophages is low in the intima in the early stage of cutaneous arteritis. Immunologic Research 68:3, pages 152-160.
Crossref
Alfredo Sadun & Lynn Gordon. (2020) Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?. Journal of Neuro-Ophthalmology 40:1, pages 117-121.
Crossref
Peter J. Lee & Georgios I. Papachristou. (2019) New insights into acute pancreatitis. Nature Reviews Gastroenterology & Hepatology 16:8, pages 479-496.
Crossref
Tomas Smutny, Ivan Barvik, Tomas Veleta, Petr Pavek & Tomas Soukup. (2019) Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis. Journal of Clinical Medicine 8:5, pages 582.
Crossref
Shilpa Kodati & Christina Y. Weng. (2019) Current and Emerging Pharmaceutical Therapies for Noninfectious Uveitis. International Ophthalmology Clinics 59:1, pages 111-126.
Crossref
Carlo Salvarani & Gulen Hatemi. (2019) Management of large-vessel vasculitis. Current Opinion in Rheumatology 31:1, pages 25-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.